Vivek Garipalli
Director, 10% Owner · CLOVER HEALTH INVESTMENTS, CORP. /DE
- 2025
- Aug 8, 2025
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vivek Garipalli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Toy - $3.70M in CLOV purchases and sales in the last 12 months
- Conrad Wai - $2.41M in CLOV purchases and sales in the last 12 months
- Brady Patrick Priest - $725K in CLOV purchases and sales in the last 12 months
- Jamie L. Reynoso - $481K in CLOV purchases and sales in the last 12 months
- Karen Soares - $337K in CLOV purchases and sales in the last 12 months
- Carladenise Armbrister Edwards - $230K in CLOV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vivek Garipalli?
Vivek Garipalli is a corporate insider, tracked as Director, 10% Owner of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Vivek Garipalli last file a Form 4?
The only primary Form 4 on record is dated 8 August 2025.
Has Vivek Garipalli been buying or selling stock?
Recorded transactions: 2 open-market purchases ($999K) and 0 open-market sales across all tracked filings.